http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#Head http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#provenance http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#pubinfo http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion http://purl.obolibrary.org/obo/DOID_1558 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1558 http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00722 http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association http://www.w3.org/2000/01/rdf-schema#label "PRINIVIL is contraindicated in patients with: a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor hereditary or idiopathic angioedema. Do not coadminister aliskiren with PRINIVIL in patients with diabetes [see Drug Interactions (7.4) PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor [see Warnings and Precautions (5.2) Drug Interactions (7.8) Angioedema or a history of hereditary or idiopathic angioedema ( 4 Hypersensitivity ( 4 Coadministration of aliskiren with PRINIVIL in patients with diabetes ( 4 7.4 PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor ( 4" http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00722 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#provenance http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#pubinfo http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig http://purl.org/nanopub/x/hasSignature TGKotDMizhLpKLj1hlHyxQ8SVIw8wUoeTur0vtFLNSzbYvfk4aAZd6ydLbBDdO1sHcomTJFZP6sOt6AwZa6ticlDtFyVOHm5dI5T3J7cRKAhseshr9SbfsAnuRwAqwrbYfY0Y89YIOaqD029hYsjlJ1XTguhBzKR4vZF002DojQ= http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://purl.org/dc/terms/created 2021-08-23T12:15:44.690+02:00 http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY